SHPH•benzinga•
Shuttle Pharmaceuticals Provides Corporate Update On Phase 2 Glioblastoma Trial Enrollment, Diagnostics Advancements With UCSF, Launch Of New Corporate Website, And $237,500 Investment By CEO Dr. Anatoly Dritschilo And Other Investors In Recent Financing
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga